Niacin: How it works to reduce cravings

Niacin (Vitamin B3), also referred to as nicotinic acid or niacinamide, is viewed in orthomolecular medicine as an adjunctive strategy for managing addiction disorders, particularly alcohol use disorders. The primary aim is not to cure the addiction directly, but to address neurobiochemical imbalances that may intensify cravings, depressive manifestations, and relapse probabilities.

The proposed mechanism of action relies on biochemical pathways that correct metabolic deficiencies and mitigate neurochemical disruptions. This concept was historically pioneered by the Canadian psychiatrist Abram Hoffer, who utilized high doses of niacin during the 1950s and 1960s to alleviate symptoms including persistent cravings, mood instabilities, and withdrawal effects.

Hoffer identified niacin as a means to restore the nicotinamide adenine dinucleotide (NAD) balance, which becomes disrupted due to prolonged alcohol consumption. NAD functions as a cofactor in redox reactions and is crucial for cellular energy metabolism, including in neurons. The breakdown of alcohol depletes NAD, leading to deficiencies that promote conditions like pellagra (a niacin deficiency syndrome), marked by dermatitis, diarrhea, and dementia—the latter associating with psychological strains and cravings.

Bill W., founder of Alcoholics Anonymous, successfully used niacin to combat his cravings and depression after alcohol withdrawal. He wrote a booklet about it and also used it with a group of former addicts.

Biochemical Principles for Reducing Cravings #

At the cellular level, niacin acts as a precursor for NAD and NADP, aiding in the hepatic and cerebral degradation of ethanol. Chronic alcohol intake inhibits the conversion of tryptophan to niacin, disturbing the serotonin levels and contributing to depressive states that heighten cravings. Supplemental niacin administration can interrupt this cycle by enhancing NAD availability, stabilizing metabolism, and attenuating inflammatory responses in the nervous system.

This results in diminished cravings, as balanced moods and lowered anxiety reduce the impulsive urge to consume. Additional benefits include supporting the glutamate–GABA equilibrium, which eases hyperexcitable states in the reward system (such as in the nucleus accumbens) and thereby decreases sensitivity to addiction triggers. Clinical observations suggest that daily doses ranging from 500 to 3000 mg may lower cravings within weeks, although controlled trials yield inconsistent findings, and the orthomolecular approach has not yet become a standard medical practice.

Links to Schizophrenia Studies #

Hoffer’s main research focus was on treating schizophrenia, where he regarded niacin as a key component of orthomolecular therapy. During the 1960s, lacking advanced imaging techniques like fMRI or detailed neurotransmitter assessments, his theories depended on clinical insights and biochemical frameworks. He proposed that schizophrenia arises from oxidative stress, particularly through the formation of adrenochrome—a hallucinogenic oxidation product of adrenaline—that niacin neutralizes as an antioxidant.

This hypothesis drew parallels to alcoholism, as both conditions exhibit NAD shortages and altered tryptophan metabolism, leading to psychotic or depressive symptoms. Contemporary research offers a more nuanced view: niacin may alleviate glutamatergic dysfunctions relevant to schizophrenia and addiction by modulating NMDA receptors and reducing inflammation.

Nevertheless, the evidence remains largely anecdotal. Recent randomized studies do not confirm broad efficacy but highlight potential advantages in cases with comorbid deficiencies. Incorporating modern techniques, such as genomics and metabolomics, could in the future determine whether tailored niacin dosages benefit specific subtypes of dependency or psychoses.

---

---